This cluster is routine, the dollar value is negligible relative to Spyre's $6.9B market cap. The CMO's derivative exercise is a standard cashless exercise, not a signal. No action warranted. Monitor for any material change in insider selling velocity (e.g., >$10M in a 7-day window) before assigning directional significance.
SYRE drugs
SYRE drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 1 $69.42entry
- T+1 · 7mo ago −0.42%α −0.08% · $69.13
- T+5 · 6mo ago +5.30%α +2.95% · $73.10
- T+20 · 6mo ago +1.61%α −3.67% · $70.54
- T+60 · 4mo ago +43.99%α +40.92% · $99.96
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
CEO and CMO sold a combined $1.85M in open-market sales at ~$69.50, representing 0.027% of Spyre's $6.9B market cap. The CMO also exercised and sold shares from a derivative grant, a routine cashless exercise pattern. The dollar amount is trivial relative to market cap, making this a routine cluster with no material directional signal.
Key Financial Metrics
Key Facts
- CEO Turtle Cameron sold 5,300 shares for $369K on May 1, 2026
- CMO Sloan Sheldon sold 21,306 shares for $1.48M on May 1, 2026
- CMO also exercised 78,333 derivative shares at $27.46 ($2.15M) and 78,333 at $0 (non-cash award), these are non-cash events
- Total open-market sales of $1.85M represent just 0.027% of $6.9B market cap
- No open-market purchases in the cluster
Financial Impact
Total insider sales of $1.85M, or 0.027% of market cap, immaterial
Risk Factors
- Insider selling could accelerate ahead of a catalyst event (e.g., clinical data readout)
- CEO selling, while small, is the first CEO sale in the recent 30-day window, worth tracking
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-SYRE-1777685708871 |
Track record
36 reports on SYRE
8 of 12 bullish or bearish reports moved the stock their way by T+60. Best: +54.27% at T+60 after the Apr 13, 2026 report. 15 of 21 went positive at some point.
Filters
- Nov 3, 202613d ago 8-K Neutral 5/10 No price data
- Nov 3, 202613d ago Press Release Bearish 5/10 Entry $99.04 Now $99.37 −0.33% settles Feb 2
- Oct 12, 20265w ago Institutional Cluster Bullish 4/10 Entry $85.90 Now $99.37 +15.68% settles Jan 7
- Oct 9, 20265w ago SC 13D/A Neutral 3/10 Entry $85.90 Now $99.37 +15.68% settles Jan 7
- Oct 7, 20265w ago 8-K Bearish 5/10 Entry $80.85 Now $99.37 −22.91% settles Jan 4
- Oct 6, 20265w ago 424B5 Bearish 6/10 Entry $80.85 Now $99.37 −22.91% settles Jan 4
- Oct 5, 20266w ago Press Release Bearish 6/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
- Oct 5, 20266w ago 424B5 Bearish 5/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
- Oct 5, 20266w ago Press Release Bearish 5/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
- Oct 2, 20266w ago Insider Cluster Bearish 4/10 Entry $92.72 Now $99.37 −7.17% settles Dec 30
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers